Literature DB >> 28106046

OBP-401-GFP telomerase-dependent adenovirus illuminates and kills high-metastatic more effectively than low-metastatic triple-negative breast cancer in vitro.

S Yano1,2,3, K Takehara1,2,3, H Kishimoto3, H Tazawa4, Y Urata5, S Kagawa3, M Bouvet2, T Fujiwara3, R M Hoffman1,2.   

Abstract

We previously described the development of a highly-invasive, triple-negative breast cancer (TNBC) variant using serial orthotopic implantation of MDA-MB-231 human breast cancer in nude mice. The isolated variant is highly invasive in the mammary gland and metastasized to lymph nodes in 10 of 12 mice compared with 2 of 12 of the parental cell line. OBP-401 is a telomerase-dependent cancer-specific, green fluorescent protein (GFP)-expressing adenovirus. OBP-401 was used to infect parental MDA-MB-231P cells and high-metastatic MDA-MB-231H and MDA-MB-231HLN isolated from a lymph node metastasis and MDA-MB-231HLM isolated from a lung metastasis. Time-course imaging showed that OBP-401 labeled MDA-MB-231HP, MDA-MB-231HLN, and MDA-MB-231HLM cells more brightly than MDA-MB-231 parental cells. OBP-401 killed MDA-MB-231H, MDA-MB-231HLN, and MDA-MB-231HLM cells more efficiently than MDA-MB-231P parental cells. These results indicate that OBP-401 could infect, label and then kill high-metastatic MDA-MB-231 more efficiently than low-metastatic MDA-MB-231.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28106046     DOI: 10.1038/cgt.2016.67

Source DB:  PubMed          Journal:  Cancer Gene Ther        ISSN: 0929-1903            Impact factor:   5.987


  4 in total

1.  GFP labeling kinetics of triple-negative human breast cancer by a killer-reporter adenovirus in 3D Gelfoam® histoculture.

Authors:  Shuya Yano; Kiyoto Takehara; Shinji Miwa; Hiroyuki Kishimoto; Hiroshi Tazawa; Yasuo Urata; Shunsuke Kagawa; Michael Bouvet; Toshiyoshi Fujiwara; Robert M Hoffman
Journal:  In Vitro Cell Dev Biol Anim       Date:  2017-02-23       Impact factor: 2.416

Review 2.  Tumor-targeted fluorescence labeling systems for cancer diagnosis and treatment.

Authors:  Hiroshi Tazawa; Kunitoshi Shigeyasu; Kazuhiro Noma; Shunsuke Kagawa; Fuminori Sakurai; Hiroyuki Mizuguchi; Hisataka Kobayashi; Takeshi Imamura; Toshiyoshi Fujiwara
Journal:  Cancer Sci       Date:  2022-04-18       Impact factor: 6.518

Review 3.  Real-Time Fluorescence Image-Guided Oncolytic Virotherapy for Precise Cancer Treatment.

Authors:  Shuya Yano; Hiroshi Tazawa; Hiroyuki Kishimoto; Shunsuke Kagawa; Toshiyoshi Fujiwara; Robert M Hoffman
Journal:  Int J Mol Sci       Date:  2021-01-17       Impact factor: 5.923

4.  Patient-derived pancreatic tumour organoids identify therapeutic responses to oncolytic adenoviruses.

Authors:  Giulia Raimondi; Ana Mato-Berciano; Silvia Pascual-Sabater; Maria Rovira-Rigau; Miriam Cuatrecasas; Constantino Fondevila; Santiago Sánchez-Cabús; Harry Begthel; Sylvia F Boj; Hans Clevers; Cristina Fillat
Journal:  EBioMedicine       Date:  2020-05-24       Impact factor: 8.143

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.